PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Symptom | C0042373|vascular diseases |
| Sentences | 10 |
| PubMedID- 24754876 | vascular diseases: sum of myocardial infarction, congestive heart failure, claudication and stroke self-reported. |
| PubMedID- 25671949 | Knowledge of modifiable risk factors of cardiovascular diseases among patients with acute myocardial infarction. |
| PubMedID- 20969786 | vascular diseases: sum of myocardial infarction, congestive heart failure, claudication and stroke self-reported. |
| PubMedID- 24580799 | Self-reported illnesses included cardiovascular diseases (history of heart failure, myocardial infarction, angina pectoris and hypertension) and diabetes mellitus. |
| PubMedID- 22080635 | Forty-one patients (37.3%) were critically ill due to cardiovascular diseases (23.6% with myocardial infarction); 51 (46.4%) had severe infections (21.8% with h1n1); electrolyte disturbance (21.8%); or pulmonary illness (15.5%). |
| PubMedID- 25891725 | Cardiovascular diseases associated with myocardial infarction are among the major causes of death worldwide due to the limited regenerative capacity of cardiac tissues. |
| PubMedID- 23897866 | Small-animal studies suggest that mirs might offer novel therapeutic targets in cardiovascular diseases such as cardioprotection of murine hearts after myocardial infarction via mir-92a inhibitors. |
| PubMedID- 20610900 | Background: although hypertension is a well-documented risk factor for cardiovascular diseases, including myocardial infarction and stroke, in adults, only recently has knowledge about childhood hypertension increased significantly. |
| PubMedID- 20802255 | In addition to its metabolic functions, adiponectin exerts multiple protective effects against cardiovascular diseases, including alleviation of stroke (11), myocardial infarction (12), and diabetic cardiomyopathy (13). |
| PubMedID- 23305859 | Conclusions: elevated rhr is associated with increased risk for mortality but not for myocardial infarction or stroke in patients with manifest vascular diseases irrespective of location of vascular disease. |
Page: 1